194 related articles for article (PubMed ID: 19252273)
21. Modulation of neuronal nicotinic receptor by quinolizidine alkaloids causes neuroprotection on a cellular Alzheimer model.
Araya JA; Ramírez AE; Figueroa-Aroca D; Sotes GJ; Pérez C; Becerra J; Saez-Orellana F; Guzmán L; Aguayo LG; Fuentealba J
J Alzheimers Dis; 2014; 42(1):143-55. PubMed ID: 24825567
[TBL] [Abstract][Full Text] [Related]
22. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.
Takada-Takatori Y; Kume T; Izumi Y; Ohgi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
Biol Pharm Bull; 2009 Mar; 32(3):318-24. PubMed ID: 19252271
[TBL] [Abstract][Full Text] [Related]
23. [Neuroprotective effects of alpha7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease].
Qi XL; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):51-5. PubMed ID: 18509986
[TBL] [Abstract][Full Text] [Related]
24. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration.
O'Neill MJ; Murray TK; Lakics V; Visanji NP; Duty S
Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):399-411. PubMed ID: 12769612
[TBL] [Abstract][Full Text] [Related]
25. Neurotrophic effects of central nicotinic receptor activation.
Belluardo N; Mudo G; Blum M; Amato G; Fuxe K
J Neural Transm Suppl; 2000; (60):227-45. PubMed ID: 11205143
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.
Kihara T; Shimohama S; Urushitani M; Sawada H; Kimura J; Kume T; Maeda T; Akaike A
Brain Res; 1998 May; 792(2):331-4. PubMed ID: 9593977
[TBL] [Abstract][Full Text] [Related]
27. Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson's disease.
Liu Y; Zeng X; Hui Y; Zhu C; Wu J; Taylor DH; Ji J; Fan W; Huang Z; Hu J
Neuropharmacology; 2015 Apr; 91():87-96. PubMed ID: 25486621
[TBL] [Abstract][Full Text] [Related]
28. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
29. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
Inden M; Takata K; Yanagisawa D; Ashihara E; Tooyama I; Shimohama S; Kitamura Y
Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
[TBL] [Abstract][Full Text] [Related]
30. Protection against the Neurotoxic Effects of β-Amyloid Peptide on Cultured Neuronal Cells by Lovastatin Involves Elevated Expression of α7 Nicotinic Acetylcholine Receptors and Activating Phosphorylation of Protein Kinases.
Zhao L; Xiao Y; Xiu J; Tan LC; Guan ZZ
Am J Pathol; 2018 Apr; 188(4):1081-1093. PubMed ID: 29341888
[TBL] [Abstract][Full Text] [Related]
31. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
[TBL] [Abstract][Full Text] [Related]
32. Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer's Dimer.
Hu S; Cui W; Mak S; Xu D; Hu Y; Tang J; Choi C; Lee M; Pang Y; Han Y
ACS Chem Neurosci; 2015 Sep; 6(9):1536-45. PubMed ID: 26147504
[TBL] [Abstract][Full Text] [Related]
33. Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice.
Kita Y; Ago Y; Takano E; Fukada A; Takuma K; Matsuda T
Psychopharmacology (Berl); 2013 Feb; 225(3):543-51. PubMed ID: 22932776
[TBL] [Abstract][Full Text] [Related]
34. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.
Mudo G; Belluardo N; Fuxe K
J Neural Transm (Vienna); 2007 Jan; 114(1):135-47. PubMed ID: 16906354
[TBL] [Abstract][Full Text] [Related]
35. Amyloid β-protein suppressed nicotinic acetylcholine receptor-mediated currents in acutely isolated rat hippocampal CA1 pyramidal neurons.
He YX; Wu MN; Zhang H; Qi JS
Synapse; 2013 Jan; 67(1):11-20. PubMed ID: 23015319
[TBL] [Abstract][Full Text] [Related]
36. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII.
Steiner RC; Heath CJ; Picciotto MR
J Neurochem; 2007 Oct; 103(2):666-78. PubMed ID: 17666046
[TBL] [Abstract][Full Text] [Related]
37. PNU282987 inhibits amyloid‑β aggregation by upregulating astrocytic endogenous αB‑crystallin and HSP‑70 via regulation of the α7AChR, PI3K/Akt/HSF‑1 signaling axis.
Ren Z; Dong Z; Xie P; Lv J; Hu Y; Guan Z; Zhang C; Yu W
Mol Med Rep; 2020 Jul; 22(1):201-208. PubMed ID: 32377707
[TBL] [Abstract][Full Text] [Related]
38. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
39. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
[TBL] [Abstract][Full Text] [Related]
40. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
Ma KG; Qian YH
Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
